Through mechanisms involving inflammatory chemokines such as CXCL5, a potential target for MALAT1, the development of fibrosis in NASH could implicate functionally relevant differences in MALAT1 expression could. Here, MALAT1 is linked to metabolic dysfunction-associated steatohepatitis.